☰

Menglin Wang - Publications

Affiliations: 
Eshelman School of Pharmacy University of North Carolina, Chapel Hill, Chapel Hill, NC 
Tree Info Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Xu S, Zheng S, Ma N, Zhang H, Shi J, Huang J, Luo N, Wang M, Xiong Y. Rhein potentiates doxorubicin in treating triple negative breast cancer by inhibiting cancer-associated fibroblasts. Biochemical Pharmacology. 116139. PMID 38499109 DOI: 10.1016/j.bcp.2024.116139  0.396
2023 Wang M, Rousseau B, Qiu K, Huang G, Zhang Y, Su H, Le Bihan-Benjamin C, Khati I, Artz O, Foote MB, Cheng YY, Lee KH, Miao MZ, Sun Y, Bousquet PJ, et al. Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses. Nature Biotechnology. PMID 37749267 DOI: 10.1038/s41587-023-01957-8  0.644
2023 Zhang H, Chen L, Zhao Y, Luo N, Shi J, Xu S, Ma L, Wang M, Gu M, Mu C, Xiong Y. Relaxin-encapsulated polymeric metformin nanoparticles remodel tumor immune microenvironment by reducing CAFs for efficient triple-negative breast cancer immunotherapy. Asian Journal of Pharmaceutical Sciences. 18: 100796. PMID 37008735 DOI: 10.1016/j.ajps.2023.100796  0.458
2022 Yu Z, Guo J, Liu Y, Wang M, Liu Z, Gao Y, Huang L. Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma. Journal of Nanobiotechnology. 20: 9. PMID 34983554 DOI: 10.1186/s12951-021-01205-8  0.456
2021 Wang Y, Yu J, Li D, Zhao L, Sun B, Wang J, Wang Z, Zhou S, Wang M, Yang Y, Liu H, Zhang H, Lv Q, Jiang Q, He Z, et al. Paclitaxel derivative-based liposomal nanoplatform for potentiated chemo-immunotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 341: 812-827. PMID 34953979 DOI: 10.1016/j.jconrel.2021.12.023  0.372
2021 Xi Y, Li Y, Xu P, Li S, Liu Z, Tung HC, Cai X, Wang J, Huang H, Wang M, Xu M, Ren S, Li S, Zhang M, Lee YJ, et al. The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1. Science Advances. 7: eabg9241. PMID 34516906 DOI: 10.1126/sciadv.abg9241  0.49
2021 Zhou X, Liu Y, Hu M, Wang M, Liu X, Huang L. Relaxin gene delivery modulates macrophages to resolve cancer fibrosis and synergizes with immune checkpoint blockade therapy. Science Advances. 7. PMID 33597232 DOI: 10.1126/sciadv.abb6596  0.661
2021 Liu Y, Tiruthani K, Wang M, Zhou X, Qiu N, Xiong Y, Pecot CV, Liu R, Huang L. Tumor-targeted gene therapy with lipid nanoparticles inhibits tumor-associated adipocytes and remodels the immunosuppressive tumor microenvironment in triple-negative breast cancer. Nanoscale Horizons. PMID 33587080 DOI: 10.1039/d0nh00588f  0.583
2021 Hu M, Wang Y, Liu Z, Yu Z, Guan K, Liu M, Wang M, Tan J, Huang L. Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis. Nature Nanotechnology. PMID 33495618 DOI: 10.1038/s41565-020-00836-6  0.61
2020 Harrison EB, Porrello A, Bowman BM, Belanger AR, Yacovone G, Azam SH, Windham IA, Ghosh SK, Wang M, McKenzie N, Waugh TA, Van Swearingen AED, Cohen SM, Allen DG, Goodwin TJ, et al. A circle RNA regulatory axis promotes lung squamous metastasis via CDR1-mediated regulation of Golgi trafficking. Cancer Research. PMID 32978168 DOI: 10.1158/0008-5472.CAN-20-1162  0.361
2020 Ye H, Wang K, Lu Q, Zhao J, Wang M, Kan Q, Zhang H, Wang Y, He Z, Sun J. Nanosponges of circulating tumor-derived exosomes for breast cancer metastasis inhibition. Biomaterials. 242: 119932. PMID 32169772 DOI: 10.1016/j.biomaterials.2020.119932  0.407
2020 Xu H, Hu M, Liu M, An S, Guan K, Wang M, Li L, Zhang J, Li J, Huang L. Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model. Biomaterials. 235: 119769. PMID 31986348 DOI: 10.1016/J.Biomaterials.2020.119769  0.645
2019 Wang M, Zhai Y, Ye H, Lv Q, Sun B, Luo C, Jiang Q, Zhang H, Xu Y, Jing Y, Huang L, Sun J, He Z. High Co-loading Capacity and Stimuli-Responsive Release Based on Cascade Reaction of Self-Destructive Polymer for Improved Chemo-Photodynamic Therapy. Acs Nano. PMID 31188559 DOI: 10.1021/acsnano.9b02096  0.419
2019 Ye H, Wang K, Wang M, Liu R, Song H, Li N, Lu Q, Zhang W, Du Y, Yang W, Zhong L, Wang Y, Yu B, Wang H, Kan Q, et al. Bioinspired nanoplatelets for chemo-photothermal therapy of breast cancer metastasis inhibition. Biomaterials. 206: 1-12. PMID 30921730 DOI: 10.1016/j.biomaterials.2019.03.024  0.377
2018 Yang B, Wang K, Zhang D, Sun B, Ji B, Wei L, Li Z, Wang M, Zhang X, Zhang H, Kan Q, Luo C, Wang Y, He Z, Sun J. Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy. Biomaterials Science. PMID 30255178 DOI: 10.1039/c8bm00899j  0.356
2018 Shi T, Wang M, Li H, Wang M, Luo X, Huang Y, Wang HH, Nie Z, Yao S. Simultaneous Monitoring of Cell-surface Receptor and Tumor-targeted Photodynamic Therapy via TdT-initiated Poly-G-Quadruplexes. Scientific Reports. 8: 5551. PMID 29615769 DOI: 10.1038/s41598-018-23902-5  0.312
2017 Jiang M, Zhang R, Wang Y, Jing W, Liu Y, Ma Y, Sun B, Wang M, Chen P, Liu H, He Z. Reduction-sensitive Paclitaxel Prodrug Self-assembled Nanoparticles with Tetrandrine Effectively Promote Synergistic Therapy Against Drug-sensitive and Multidrug-resistant Breast Cancer. Molecular Pharmaceutics. PMID 28895735 DOI: 10.1021/acs.molpharmaceut.7b00381  0.322
2016 Ren G, Liu D, Guo W, Wang M, Wu C, Guo M, Ai X, Wang Y, He Z. Docetaxel prodrug liposomes for tumor therapy: characterization, in vitro and in vivo evaluation. Drug Delivery. 1-32. PMID 26965023 DOI: 10.3109/10717544.2016.1165312  0.374
Show low-probability matches.